Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Valgen Medtech has developed and commercialized several interventional devices for structural heart disease, most notably the DragonFly™ Transcatheter Mitral Valve Repair System. The DRAGONFLY-DMR pivotal trial demonstrated significant clinical success in treating chronic symptomatic 3+ to 4+ degenerative mitral regurgitation at prohibitive surgical risk. Over 300 patients have been treated with this system in China, with positive safety and efficacy results presented at major international conferences[4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Valgen Medtech.